Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment
出版年份 2018 全文链接
标题
Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment
作者
关键词
Mild cognitive impairment, CSF biomarkers, Aβ42/40 ratio, Alzheimer’s disease
出版物
Alzheimers Research & Therapy
Volume 10, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-04-04
DOI
10.1186/s13195-018-0362-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting
- (2017) Christelle Gervaise-Henry et al. JOURNAL OF ALZHEIMERS DISEASE
- Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer’s disease patients
- (2017) António José Gabriel et al. NEUROSCIENCE LETTERS
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
- (2017) Piotr Lewczuk et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
- (2017) Lutz Frölich et al. Alzheimers Research & Therapy
- Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment
- (2017) Shorena Janelidze et al. JAMA Neurology
- Multicenter Analytical Validation of Aβ40 Immunoassays
- (2017) Linda J. C. van Waalwijk van Doorn et al. Frontiers in Neurology
- Oxidative Damage and Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment
- (2017) Inês Baldeiras et al. JOURNAL OF ALZHEIMERS DISEASE
- Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years
- (2017) Joakim Hertze et al. JOURNAL OF ALZHEIMERS DISEASE
- Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
- (2016) Natalia Lelental et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
- (2016) Panagiotis Alexopoulos et al. Alzheimers Research & Therapy
- CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
- (2016) Shorena Janelidze et al. Annals of Clinical and Translational Neurology
- Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease
- (2015) Daniela Bertens et al. Alzheimers & Dementia
- Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
- (2015) Kaj Blennow et al. Alzheimers & Dementia
- Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
- (2015) Stephanie J. B. Vos et al. BRAIN
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total-Aβ42/Aβ40 ratio
- (2015) J. Randall Slemmon et al. JOURNAL OF NEUROCHEMISTRY
- Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease
- (2015) Inês Baldeiras et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression
- (2015) A. Caroli et al. NEUROLOGY
- Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
- (2015) Julien Dumurgier et al. Alzheimers Research & Therapy
- Chasing the Effects of Pre-Analytical Confounders – A Multicenter Study on CSF-AD Biomarkers
- (2015) Maria João Leitão et al. Frontiers in Neurology
- Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer’s Disease
- (2015) Aline Dorey et al. Frontiers in Neurology
- Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
- (2013) A. Prestia et al. NEUROLOGY
- Amyloid positron emission tomography with 18F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer’s disease
- (2012) Ranjan Duara et al. Alzheimers & Dementia
- Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
- (2012) Marta del Campo et al. Biomarkers in Medicine
- The National Institute on Aging-Alzheimer’s Association research criteria for mild cognitive impairment due to Alzheimer’s disease: predicting the outcome
- (2012) Liang-Hao Guo et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
- (2011) Niklas Mattsson et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
- (2011) Clifford R. Jack et al. ANNALS OF NEUROLOGY
- Montreal Cognitive Assessment (MoCA): Normative study for the Portuguese population
- (2011) Sandra Freitas et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers
- (2011) Maartje I. Kester et al. NEUROBIOLOGY OF AGING
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
- (2009) Pieter Jelle Visser et al. LANCET NEUROLOGY
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
- (2007) Miroslaw Brys et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now